未登录

R

Ruggero La Rosa

Rigshospitalet

H指数:16

被引数:1,358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Carbapenem-resistance oprD mutations reshape Pseudomonas aeruginosa host-pathogen interactions during infection

碳青霉烯耐药性oprD突变重塑铜绿假单胞菌在感染期间的宿主-病原体相互作用

Nature Communications

IF15.7

2026-04-100

OAAI

Rethinking antimicrobial resistance diagnostics: beyond standardized susceptibility testing

重新审视抗菌药物耐药性诊断：超越标准化药敏试验

Trends in Microbiology

IF14.9

2026-04-030

PRE

Cell-type-independent infection dynamics of clinical Pseudomonas aeruginosa isolates in human airway epithelial models

临床**Pseudomonas aeruginosa**分离株在人体气道上皮模型中的细胞类型无关感染动力学

IF6.9

2026-02-090

OAAI

Human airway model reveals host-pathogen co-infection dynamics of Staphylococcus aureus and Pseudomonas aeruginosa

人呼吸道模型揭示了金黄色葡萄球菌和铜绿假单胞菌的宿主-病原体共感染动力学

ISME Communications

IF6.1

2026-01-010

OA

Pseudomonas aeruginosa: persistence beyond antibiotic resistance

铜绿假单胞菌：抗生素耐药性后的持久性

Trends in Microbiology

IF14.9

2025-05-280

OAAI

Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa

NATURE COMMUNICATIONS

IF15.7

2024-10-160

OAAI

Adaptive Evolution of Pseudomonas aeruginosa in Human Airways Shows Phenotypic Convergence Despite Diverse Patterns of Genomic Changes

MOLECULAR BIOLOGY AND EVOLUTION

IF5.3

2024-02-140

OAAI

Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author's response

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2022-12-011

OA

Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2022-12-014

OA

Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution

ANTIBIOTICS-BASEL

IF4.6

2022-03-2123

OA

High-throughput dilution-based growth method enables time-resolved exo-metabolomics of Pseudomonas putida and Pseudomonas aeruginosa

MICROBIAL BIOTECHNOLOGY

IF5.2

2021-07-2912

OAAI

Compensatory evolution of Pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis

NATURE COMMUNICATIONS

IF15.7

2021-05-2743

OAAI

Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis

囊性纤维化患者铜绿假单胞菌的适应和进化

NATURE REVIEWS MICROBIOLOGY

IF103.3

2020-11-19276

PREAI

Adapting to the Airways: Metabolic Requirements of Pseudomonas aeruginosa during the Infection of Cystic Fibrosis Patients

适应气道: 囊性纤维化患者感染期间铜绿假单胞菌的代谢要求

IF3.7

2019-10-1652

OAAI

Structure of Pseudomonas aeruginosa ribosomes from an aminoglycoside-resistant clinical isolate

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2019-10-1426

OAAI

Pseudomonas putida KT2440 metabolism undergoes sequential modifications during exponential growth in a complete medium as compounds are gradually consumed

ENVIRONMENTAL MICROBIOLOGY

IF4

2019-04-2116

OAAI

Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa

IF4.7

2018-05-0261

OAAI

Influence of the Crc regulator on the hierarchical use of carbon sources from a complete medium in Pseudomonas

ENVIRONMENTAL MICROBIOLOGY

IF4

2016-01-1838

OAAI

The Crc/CrcZ-CrcY global regulatory system helps the integration of gluconeogenic and glycolytic metabolism in Pseudomonas putida

ENVIRONMENTAL MICROBIOLOGY

IF4

2015-03-2743

PREAI

The Crc and Hfq proteins of Pseudomonas putida cooperate in catabolite repression and formation of ribonucleic acid complexes with specific target motifs

ENVIRONMENTAL MICROBIOLOGY

IF4

2014-06-0294

PREAI